(Date:8/7/2008)...get to hospital quickly enough to limit damage, st...y News) -- Most people who have strokes don,t act ...t that can limit brain damage, a new study finds. ...don,t realize that they are having a stroke," said...f epidemiology at the University of North Carolina...
(Date:8/7/2008)...upport of activities fostering total health in ...ENA, Calif., Aug. 7 /PRNewswire/ -- Kaiser Permane...it organization, today announced that,Kaiser Perma... Pasadena,Marathon. The inaugural race, calendared...ent for Pasadena Forward., Kaiser Permanente Sout...
(Date:8/7/2008)...t practices in consumer decision-making and,consum...ement spectrum, WASHINGTON, Aug. 7 /PRNewswire-US...of the nation,s foremost thought leaders in health...est Practices in Health Care,Consumer Empowerment ...ecognize innovative and proven programs from healt...
(Date:8/7/2008)...swire-USNewswire/ -- The U.S. Government,through ...ID), is providing,an initial $50,000 to the Togole... supplies to the flood-affected population in Togo...ding in central and,southeastern Togo, including t...me. The UN Development Program estimates that the ...
Breaking Medicine News(10 mins):Health News:Many Miss Out on Stroke Treatment 2Health News:Many Miss Out on Stroke Treatment 3Health News:Kaiser Permanente Becomes Presenting Sponsor for Pasadena Marathon 2Health News:URAC Reveals Distinguished Judges' Panel for 2009 Best Practices in Health Care Consumer Empowerment and Protection Awards 2Health News:URAC Reveals Distinguished Judges' Panel for 2009 Best Practices in Health Care Consumer Empowerment and Protection Awards 3(Date:8/5/2008)...n Wednesday, August 6, 2008 at 8:00 ...wswire-FirstCall/ -- Isolagen(TM), Inc. (Amex:,ILE...afety results from two,pivotal, Phase III clinical...olagen Therapy(TM) for the treatment of nasolabial...n FDA Special Protocol Assessment (SPA), met,all p...
(Date:8/5/2008)... to Antiretroviral Therapy Respond ...ug. 5 /- Initial treatment,...ng of Abbott,s (NYSE:,ABT) protease inhibitor Kale...ar results for controlling the virus (reducing the...(increasing CD4 cells) in women compared to,men an...
(Date:8/5/2008)...e/ -- Tolerx, Inc., a,biopharmaceutical company en...erapies for the treatment of immune-mediated disea...r, has moved a modified version of TRX1,MTRX1011A...clinical trial,that has begun enrolling patients. ...lerability of both single and multiple doses of MT...
(Date:8/5/2008)...-- Cara Therapeutics, Inc. today,announced complet...eration,peripherally acting kappa opioid agonist,...te and chronic pain. The drug candidate was safe a...resulted in plasma levels of,CR845 expected to be ...dition, CR845 infusion triggered a quantitative en...
Breaking Medicine Technology:Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant 2Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant 3Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant 4Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant 5Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 2Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 3Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 4Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 5Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 6Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 7Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines 8Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 2Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 3Cara Therapeutics Announces Successful Completion of Phase I Clinical Trial of Novel Analgesic, CR845 2Tips from the Journals of the American Society for Microbiology 762 1Tips from the Journals of the American Society for Microbiology 762 2Tips from the Journals of the American Society for Microbiology 762 3Breakthrough research identifies how cells from pigs may cure diabetes 759 1Breakthrough research identifies how cells from pigs may cure diabetes 759 2When proteins antibodies and other biological molecules kiss a new kind of biosensor can tell 756 1When proteins antibodies and other biological molecules kiss a new kind of biosensor can tell 756 2When proteins antibodies and other biological molecules kiss a new kind of biosensor can tell 756 3New technique can be breakthrough for early cancer diagnosis 753 1...ALT LAKE CITY, June 04, 2007 /PRNewswire-FirstCall...sults of a 340 patient,randomized Phase III clinic...a therapy to chemotherapy were presented at the an...conference underway in,Chicago, Illinois. Accordin... conducted at nine major European cancer treatment...
...Analysis of Phase III Data Presented at ASCO -, CH...estigators,reported today that Soliris(TM) (eculiz...moglobinuria (PNH) developed by Alexion,Pharmaceut...ith PNH,who have a history of aplastic anemia (AA)...ficantly reduced red blood cell,destruction (hemol...
Other Medicine Technology:Hyperthermia Plus Chemotherapy Nearly Doubles Disease-Free Survival,Compared to Chemotherapy Alone for Sarcoma Cancer Patients 2Hyperthermia Plus Chemotherapy Nearly Doubles Disease-Free Survival,Compared to Chemotherapy Alone for Sarcoma Cancer Patients 3Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 2Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 3Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 4Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 5Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 6Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 7Coaptation forceps. Insulated.
Semkin forceps with stops. Insulated.
Scoville-Greenwood bayonet forceps
Angled 60 degree blades 5.5 mm.
Medicine Products: